New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 28, 2012
07:13 EDTPFPTProofpoint weakness unjustified, says RBC Capital
After Proofpoint's stock tumbled about 25% after reporting Q3 results that RBC Capital views as strong ,the firm believes that the decline in the stock isn't indicative of its business, or the company’s competitive position. The firm maintains a $19 price target and Outperform rating on the shares.
News For PFPT From The Last 14 Days
Check below for free stories on PFPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2014
08:57 EDTPFPTImperva should be bought after negative preannouncement, says Pacific Crest
After Impreva preannounced lower than expected Q1 revenue, Pacific Crest blamed the miss on a lack of sales execution and lengthening sales cycles. However, the firm is still upbeat on Imperva's outlook, as it expects demand for security products to increase. Pacific Crest reduced its price target on Imperva to $48 from $62. It recommends buying other IT security names, including Palo Alto (PANW) and Proofpoint (PFPT), on weakness in the wake of Imperva's guidance. The firm keeps Outperform ratings on all the stocks named.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use